- Tytuł :
- Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers
- Autorzy :
- Źródło :
- Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. :1-11
-
Czasopismo naukowe